SCHEMBL625780

SCHEMBL625780

Cc1ccc(S(=O)(=O)O)c(C(F)C(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.35
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
RECQL P46063 1/20 0.35
CASP6 P55212 1/20 0.35
ELAVL1 Q15717 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 2/20 0.35
HSD17B10 Q99714 1/20 0.34
MPL P40238 1/20 0.33
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
MEP1B Q16820 1/20 0.32
AGER Q15109 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL776505 0.86 GAA (0.36) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL242353 0.84 LMNA (0.36) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL30716899 0.80 LMNA (0.38) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL30667146 0.80 LMNA (0.38) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL30666645 0.80 LMNA (0.38) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL531432 0.80 LMNA (0.47) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL9101570 0.80 LMNA (0.38) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL3743829 0.80 RAPGEF4 (0.35) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL9243134 0.79 MAPT (0.35) GAAMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL8464278 0.79 LMNA (0.37) GAAMAPTL3MBTL1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118161500-A Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use 安进公司 2024-06-11 CN disclosed
CN-114127073-B Imidazopyrimidines as EED inhibitors and use thereof 密歇根大学董事会 2024-05-31 CN disclosed
CN-117986258-A NLRP3 inflammation corpuscle inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2024-05-07 CN disclosed
CN-117836306-A Galactose glycoside derivatives as galectin-3 inhibitors 株式会社蒂奥姆生物 2024-04-05 CN disclosed
CN-114728167-B Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use 安进公司 2024-03-19 CN disclosed
CN-116348458-A Imidazolylpyrimidinylamine compounds as CDK2 inhibitors 因赛特公司 2023-06-27 CN disclosed
CN-109970629-B Process for preparing antifungal compounds 迈科维亚医药公司 2023-04-11 CN disclosed
WO-2016191935-A1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-12-08 WO disclosed
WO-2016142918-A1 PYRAZOLE DERIVATIVES AND RELATIVE USE FOR THE PREPARATION OF 1,3,4-THIADIAZOLES ISAGRO S.P.A. (IT) 2016-09-15 WO disclosed
EP-2603513-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2013-06-19 EP disclosed
CN-102471601-A Phthalocyanine compounds LINTEC CORP 2012-05-23 CN disclosed
WO-2012020848-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-02-16 WO disclosed
EP-1261589-A1 IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-04 EP disclosed
WO-2001053271-A1 IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-07-26 WO disclosed